 |
Bruton’s Tyrosine Kinase (Btk) Inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2015-05-13 00:00:00 |
| Sponsor | Acerta Pharma BV;Molenstraat 110, 5342 CC Oss; |
| |
Bruton’s Tyrosine Kinase (Btk) Inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2015-05-13 00:00:00 |
| Sponsor | Acerta Pharma BV;Molenstraat 110, 5342 CC Oss; |